RCKT · Rocket Pharmaceuticals, Inc.

Summary

Rocket Pharmaceuticals, Inc. entered into a Sales Agreement on March 10, 2026, and upon entry terminated its prior at-the-market sales agreement with Cowen. The filing includes exhibits consisting of an opinion from K&L Gates LLP and the Sales Agreement, both dated March 10, 2026.

Key takeaways

• Entered Sales Agreement on 2026-03-10
• Terminated prior at-the-market sales agreement with Cowen
• Exhibit 5.1: Opinion of K&L Gates LLP dated 2026-03-10
• Exhibit 10.1: Sales Agreement dated 2026-03-10